MicrobiologybioRxiv
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Y. Weisblum, F. Schmidt, F. Zhang…·P. D. Bieniasz
The paper shows SARS-CoV-2 variants resistant to neutralizing antibodies can be selected and are present in circulating populations, suggesting the need for combination antibody therapies.
DOI 10.7554/elife.61312